Health, Longevity & Biohacking
Mukherjee says CD19 CAR-T also wipes out healthy B cells
Peter Attia Drive
412 ‒ The evolving science of cancer: emerging approaches to prevention and early detection, & more
What was said
"The CAR-T cells that kill B cell leukemias and lymphomas don't just kill B cell leukemias and lymphomas. They kill all B cells."
Siddhartha Mukherjee says CD19 CAR-T responses in some B-cell blood cancers can last because the therapy targets healthy B cells as well as malignant ones. He argues people can survive without B cells, which helps explain why similar CAR-T strategies are harder to apply safely to solid organs.
Verification status
Attributed speaker claim
Egleze verified who said this and where. The underlying claim has not been independently established by Egleze.
Source and context
Egleze verified who said this and where. The underlying claim has not been independently established by Egleze.
- Speaker
- Siddhartha Mukherjee · guest
- Programme
- Peter Attia Drive
- Episode
- 412 ‒ The evolving science of cancer: emerging approaches to prevention and early detection, & more
- Clip time
- 1:07:51
- Original source
- Watch the source segment →
From this episode
Peter Attia Drive